AOD-9604 — The Precision Fat Loss Peptide That Targets Stubborn Adipose Tissue

AOD-9604

Sometimes the most interesting compounds are not the ones that make the biggest headlines. While semaglutide and tirzepatide have dominated the weight loss conversation with their dramatic clinical trial numbers, AOD-9604 has quietly built a committed and loyal following in the research peptide community — and for good reason.

This is a compound with an elegant and genuinely sophisticated mechanism. It was designed with a specific purpose — to isolate the fat-burning properties of human growth hormone and deliver them cleanly, selectively and without the systemic effects that make full growth hormone therapy complicated. For the right person with the right goal, it does exactly what it was designed to do.

AOD-9604 is not trying to compete with the GLP-1 class compounds and it doesn’t need to. It occupies a distinct and valuable space in the body composition toolkit — precision targeted fat metabolism support for active, health-conscious individuals who want something that works with their existing lifestyle rather than dramatically overriding their biology. Understanding what it does and who it is most relevant for is what this page is here to provide.

What Is AOD-9604?

AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone — specifically amino acids 176 to 191, with a tyrosine amino acid added at the N-terminus. The name reflects its pharmaceutical origin — Anti-Obesity Drug 9604 — developed by Metabolic Pharmaceuticals in Australia in the late 1990s and early 2000s.

The concept behind its development was genuinely clever. Growth hormone has well established fat-burning properties — but full growth hormone therapy brings with it a range of effects on blood sugar, IGF-1 levels, muscle and organ growth that make it unsuitable as a targeted fat loss tool. The researchers at Metabolic Pharmaceuticals identified the specific region of the growth hormone molecule responsible for its lipolytic activity and created a fragment that delivered precisely those effects — and nothing else.

AOD-9604 is a lipolytic fragment and modified peptide derived from the C-terminus of human growth hormone, originally developed to explore mechanisms related to fat metabolism, lipolysis, and how the body may burn fat or influence fat cells without affecting growth hormone levels. Aiadopters

The result is a compound with a clean and specific mechanism — one that has attracted consistent interest in the research peptide community precisely because of what it doesn’t do as much as what it does.

How Does AOD-9604 Work?

AOD-9604 targets fat metabolism through beta-3 adrenergic receptor pathways — the biological mechanism through which the body breaks down stored fat and releases it into circulation for use as energy. This process — lipolysis — is the fundamental mechanism of fat loss at a cellular level, and AOD-9604 activates it directly and selectively.

What makes this particularly compelling is the profile of what the compound does not affect. Unlike full-length growth hormone, AOD-9604 selectively targets fat metabolism through beta-3 adrenergic receptor pathways without affecting insulin sensitivity or IGF-1 levels. Amazon

This selectivity is the compound’s defining strength. No blood sugar disruption. No IGF-1 elevation. No influence on muscle growth or organ size. No interference with the body’s own growth hormone production. Just clean, targeted activation of the fat metabolism pathway — which for many people is exactly what they are looking for.

Beyond promoting the release of fat from fat cells, AOD-9604 also appears to inhibit lipogenesis — the conversion of dietary energy into stored fat. This dual action — stimulating fat breakdown while simultaneously reducing fat storage — creates a genuinely favourable body composition environment for someone who is already making good lifestyle choices and wants a compound that supports and amplifies those choices rather than substituting for them.

What Does the Research Show?

The research story for AOD-9604 rewards a nuanced reading — and the context matters significantly.

In clinical trials examining oral AOD-9604 for pharmaceutical weight loss, the results were mixed. A Phase IIb 12-week trial in 300 obese adults found 2.6 kg average weight loss with 1mg daily AOD-9604 compared with 0.8 kg in the placebo group. That is a meaningful and statistically significant difference — demonstrating clearly that the compound has real biological activity on fat metabolism in humans. A subsequent larger trial using oral administration did not reach statistical significance for weight loss — and this result led to the discontinuation of the pharmaceutical development programme. Amazon

Here is the context that most summaries of this compound omit entirely — and it matters enormously for understanding where AOD-9604 actually stands.

The trials that produced mixed results used oral administration. The research peptide community predominantly uses subcutaneous injection — a fundamentally different delivery method with significantly better bioavailability. Many clinicians report positive results with injectable protocols — most practitioners report patients noticing changes in body composition within 4 to 8 weeks of consistent daily use, particularly when combined with exercise and dietary management. Amazon

The injectable experience reported across the research peptide community is consistently more positive than the oral trial data suggests — and the bioavailability difference between oral and subcutaneous administration is a well-reasoned explanation for that discrepancy. Six clinical trials involving over 900 participants established AOD-9604’s dosing window and demonstrated a consistent and well-tolerated safety profile throughout. Audible

The honest position is this — AOD-9604 has demonstrated real biological activity on fat metabolism. Its injectable research profile is considerably more positive than its oral pharmaceutical trial history. It is a compound whose real world injectable experience outpaces its pharmaceutical trial history — and that distinction is important for anyone evaluating it seriously.

Who Is AOD-9604 Most Relevant For?

This is where AOD-9604 genuinely shines — because it is a compound with a specific ideal user, and for that person it is a genuinely valuable addition to a well-structured protocol.

The person AOD-9604 is most relevant for is already doing the work. They train consistently — resistance training, cardio or both. They eat well — adequate protein, whole foods, managed carbohydrates. They sleep well and manage their stress. They are not looking for a dramatic weight loss intervention — they are looking for a precision tool that targets the stubborn adipose tissue that tends to resist even a well-managed lifestyle. The body fat that remains despite genuine and consistent effort. The areas that seem immune to everything else.

For that person AOD-9604’s selectivity is its greatest asset. It works specifically on fat metabolism without disrupting appetite, blood sugar, hormone production or any of the other systems that matter to someone living an active and health-focused life. It is a scalpel rather than a sledgehammer — and sometimes a scalpel is exactly what is needed.

It is also increasingly interesting in the context of active recovery — with emerging research exploring its potential effects on cartilage health and joint function, which may ultimately prove as significant as its body composition applications for the athletic and active population it tends to attract.

Dosage and Protocol

Clinical trials tested doses ranging from 250mcg to 1mg daily, with most protocols settling around 300 to 500mcg for optimal fat metabolism support — six clinical trials involving over 900 participants established this window through systematic dose-finding studies. Audible

The research community protocol broadly aligns with this clinical range — with subcutaneous injection producing the most reliable and consistent results.

Standard Research Protocol:

Daily dose: 300 to 500mcg once daily
Timing: Morning administration in a fasted state — AOD-9604 works through fat metabolism pathways that are most active in a low insulin environment
Post administration fast: At least 30 minutes before eating — ideally longer for maximum effect
Cycle length: 12 to 16 weeks, followed by a break of 4 to 8 weeks before repeating

Clinical research found no additional benefit above 1mg daily — the evidence does not support aggressive dose escalation as a route to better outcomes. Amazon

Consistency within the established range over a full 12 to 16 week cycle is far more valuable than chasing a higher dose. This is a compound that rewards patience and discipline more than ambition.

Reconstitution & Mixing Guide

Understanding how to reconstitute your peptide correctly is as important as knowing the right dose — because the volume of bacteriostatic water you add to the vial directly determines the concentration of every injection you draw. Getting this wrong means either consistently underdosing or overdosing without realising it — which is why this section sits alongside the dosage guidance rather than in a separate guide.

The Basic Principle

AOD-9604 comes as lyophilised powder in a sealed vial — most commonly in amounts of 2mg, 5mg or 10mg. Bacteriostatic water is added to dissolve the powder and create a solution that can be drawn into an insulin syringe for subcutaneous administration. The amount of water you add determines the concentration — and therefore how many units on your insulin syringe correspond to your target dose.

More water = weaker concentration = more units per dose Less water = stronger concentration = fewer units per dose

Neither is right or wrong — what matters is that you know exactly what concentration you have mixed so every injection is accurate.

For AOD-9604 — Practical Mixing Examples

Using a standard 5mg (5,000mcg) vial as the reference:

Add 1ml of bacteriostatic water:

Concentration = 5,000mcg per ml
Each unit on a 100-unit insulin syringe = 50mcg
A 300mcg dose = 6 units
A 500mcg dose = 10 units

Add 2ml of bacteriostatic water (most commonly used ratio):

Concentration = 2,500mcg per ml
Each unit on a 100-unit insulin syringe = 25mcg
A 300mcg dose = 12 units
A 500mcg dose = 20 units

Add 3ml of bacteriostatic water:

Concentration = 1,666mcg per ml
Each unit on a 100-unit insulin syringe = 16.66mcg
A 300mcg dose = 18 units
A 500mcg dose = 30 units

For most people adding 2ml to a 5mg vial creates the most practical working concentration — the numbers are straightforward to calculate and the volume per injection is comfortable for subcutaneous administration.

How to Reconstitute Correctly

When adding bacteriostatic water to the vial, inject the water slowly down the inside wall of the vial rather than directly onto the peptide powder. Never shake the vial — shaking can degrade the peptide chain and reduce potency. Instead, gently swirl the vial until the powder is fully dissolved. The solution should be clear and colourless — if it appears cloudy or contains particles do not use it.

Storage After Reconstitution

Once reconstituted, AOD-9604 should be stored in the refrigerator at 2 to 8 degrees Celsius. Do not freeze a reconstituted vial. Stored correctly, a reconstituted solution is typically stable for 28 to 30 days. Always use bacteriostatic water rather than standard sterile water for multi-dose vials — the benzyl alcohol preservative is what allows the solution to remain stable and safe across multiple uses.

Lyophilised powder that has not yet been reconstituted should also be stored in the refrigerator, away from light and moisture, until ready for use.

Supporting Supplements

The supplements that best support AOD-9604’s effects are those that complement fat metabolism and maintain the cellular environment in which lipolysis operates most effectively.

L-Carnitine deserves the top spot here — it plays a direct role in transporting fatty acids into the mitochondria where they are burned for energy. In the context of a compound that stimulates the release of fat from fat cells, L-Carnitine supports the completion of that process — ensuring released fatty acids are efficiently oxidised rather than redeposited. The combination of AOD-9604 initiating lipolysis and L-Carnitine supporting oxidation is one of the most coherent supplement pairings in the body composition space.

Magnesium supports the enzymatic processes involved in fat metabolism and energy production — maintaining the cellular environment in which AOD-9604’s mechanisms operate most effectively.

Vitamin D maintains the hormonal and metabolic environment in which body composition interventions produce the most meaningful results — particularly relevant given widespread deficiency in the UK population.

Zinc supports the metabolic and hormonal processes that influence body composition — including testosterone and thyroid function, both of which have meaningful relationships with fat metabolism.

A quality multivitamin provides the broad micronutrient support that cellular fat metabolism requires — including the B vitamins directly involved in energy production pathways.

Foods That Complement AOD-9604

The nutritional approach during an AOD-9604 protocol focuses on supporting the fat metabolism mechanism while protecting the fasted morning window in which the compound operates most effectively.

The pre-administration morning fast should be kept clean — black coffee is acceptable, but anything containing calories triggers an insulin response that directly reduces the lipolytic activity AOD-9604 is designed to promote. This is one of the most important and most frequently overlooked aspects of getting the most from this compound.

Through the rest of the day the nutritional approach that best supports AOD-9604’s effects centres on lean protein at every meal — protecting and building lean tissue while the compound targets fat. Healthy fats, high fibre vegetables and reduced refined carbohydrates create the stable blood sugar and anti-inflammatory metabolic environment in which the compound works most effectively.

Oily fish two to three times per week delivers omega-3 fatty acids that support both the anti-inflammatory environment and the cardiovascular system — particularly relevant given that AOD-9604 is releasing fatty acids into circulation during its active window. Ultra-processed foods, refined sugars and alcohol disrupt insulin sensitivity and the fat oxidation pathways the compound is working to support — worth minimising throughout the protocol period.

Lifestyle Considerations

Exercise timing is one of the most practical optimisations available to anyone using AOD-9604. The compound’s lipolytic effect — releasing fatty acids from fat cells into the bloodstream — creates an ideal pre-exercise environment. Scheduling training after the morning fasted administration window allows those released fatty acids to be used as fuel during the session. AOD-9604 initiates lipolysis — exercise provides the demand that burns what has been released. That combination is significantly more effective than either in isolation.

Resistance training is particularly valuable alongside AOD-9604 for the active population this compound tends to attract — preserving and building lean tissue while the compound targets adipose tissue produces the body composition shift that most people using it are actually looking for.

Consistency is the variable that matters most with AOD-9604. Daily administration over a full 12 to 16 week cycle builds cumulative benefit in a way that intermittent use simply does not. The compound rewards a disciplined and consistent approach above everything else.

Sleep quality and stress management both influence the hormonal environment in which fat metabolism operates — elevated cortisol from poor sleep or chronic stress directly impairs lipolysis and works against the mechanism AOD-9604 is supporting.

Peptide Pairing

AOD-9604 pairs naturally with compounds that complement its targeted fat metabolism approach from different angles and timing windows.

CJC-1295 with Ipamorelin in a pre-sleep protocol is the most popular and well-reasoned pairing — growth hormone release during sleep complements daytime fat metabolism support from AOD-9604, addressing body composition across two distinct timing windows and two complementary mechanisms. Many active people running a body composition protocol use this combination as their core stack.

5-Amino-1MQ is an interesting complementary pairing — working on fat cell metabolism through NNMT enzyme inhibition while AOD-9604 works through beta-3 adrenergic pathways. The two mechanisms are genuinely distinct and potentially additive for someone whose primary focus is body composition optimisation.

TB-500 is commonly used alongside AOD-9604 by active individuals in training — supporting tissue repair and recovery while AOD-9604 addresses the body composition side of the protocol. For someone training hard during a body composition phase this combination covers both performance and physique goals simultaneously.

BPC-157 supports gut health and overall recovery — relevant for anyone whose training intensity during a body composition protocol creates additional physiological demand.

Realistic Expectations

For the right person — active, training consistently, eating well and looking for precision body composition support — AOD-9604 delivers genuine and noticeable results. Changes in body composition, particularly in the areas of stubborn adipose tissue that tend to resist lifestyle interventions alone, are typically noticeable within 4 to 8 weeks of consistent daily injectable use alongside exercise and good nutrition.

It is not a dramatic weight loss compound and it does not need to be — that is simply not what it was designed for. What it is designed for, it does with a selectivity and tolerability that few compounds in this space can match. Its safety profile across six clinical trials involving over 900 participants is excellent — no significant adverse effects have been identified within the established dosing range. Audible

Used consistently, in the morning fasted window, alongside regular training and a well-structured nutritional approach — AOD-9604 is a genuinely valuable precision tool. For the person it is designed for, it works.

For research grade AOD-9604 with independent third party Certificate of Analysis documentation, Complete Peptides supplies verified compounds at [completepeptides.co.uk]

For an overview of the full weight loss peptide landscape visit the [Weight Loss Overview]. For the complete fat loss approach combining targeted compounds with nutrition, timing and lifestyle see the [Fat Loss Protocol]. For definitions of any terms used on this page visit the [Glossary].